Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Precision diagnostics : moving towards protein biomarker signatures of clinical utility in cancer

  • Carl A K Borrebaeck
Publishing year: 2017-02-03
Language: English
Pages: 199-204
Publication/Series: Nature Reviews Cancer
Volume: 17
Issue: 3
Document type: Journal article review
Publisher: Nature Publishing Group

Abstract english

Interest in precision diagnostics has been fuelled by the concept that early detection of cancer would benefit patients; that is, if detected early, more tumours should be resectable and treatment more efficacious. Serum contains massive amounts of potentially diagnostic information, and affinity proteomics has risen as an accurate approach to decipher this, to generate actionable information that should result in more precise and evidence-based options to manage cancer. To achieve this, we need to move from single to multiplex biomarkers, a so-called signature, that can provide significantly increased diagnostic accuracy. This Opinion article focuses on the progress being made in identifying protein biomarker signatures of clinical utility, using blood-based proteomics.


  • Immunology in the medical area


  • ISSN: 1474-175X
Carl Borrebaeck
E-mail: carl.borrebaeck [at]


Department of Immunotechnology



Create Health

+46 46 222 96 13